Patient Provider Communication and Interaction in a Virtual Clinical Setting
- Conditions
- Healthy Volunteer
- Interventions
- Other: InformationOther: Information absent
- Registration Number
- NCT00669188
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Brief Summary
Summary:
A few studies have explored factors which influence patient-provider communication in a controlled setting. However, more information is needed about how different factors affect communication so that it can be improved.
Third- and fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.
At the research center, participants will use a virtual reality headset to view a virtual clinic environment and interact with a virtual patient.
After interacting with the virtual patient, participants will complete a questionnaire about their experience within the virtual clinic and other research-related information.
The total time for the study visit is 60 minutes.
Eligibility:
Third- and fourth-year medical students at least 18 years of age. You may not take part in the study if you have a history of seizures and/or are pregnant.
- Detailed Description
This study will investigate research questions regarding factors influencing patient-provider communication. Participants will interact with a virtual patient in a virtual clinical setting.
Third- or fourth-year medical students may be eligible for this study. Participants are recruited from the Washington, D.C. area.
Study participants will perform one task and complete one set of questions at the study appointment. The task involves viewing a virtual patient s health information and interacting with the virtual patient in a virtual environment clinical scenario. While in the virtual environment, the subject wears a head-mounted video unit that allows him or her to see elements of the environment. The activities in the virtual environment take about 15 minutes. The total time for the study is about 60 minutes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 326
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Information Type 1 Information genetic risk information Information Type 2 Information absent information absent
- Primary Outcome Measures
Name Time Method treatment recommendations at time of study recommendations made for the virtual patient's treatment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Institutes of Health Clinical Center
🇺🇸Bethesda, Maryland, United States